Symbiotec Pharmalab Ltd (SYMBIOTEC) — Board Meeting | 11 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board meeting scheduled to approve Q1 FY27 financial results
🔄 What Changed
None
🔮 What's Next
None
💡 Investor Takeaway
Investors should monitor the upcoming financial results for performance insights.

Symbiotec Pharmalab announced a board meeting on September 21, 2026 to approve unaudited financial results for the quarter ended June 30, 2026, and to discuss other matters with the chair's permission. The trading window for insiders remains closed until 48 hours after results are declared, as per prior intimation.

📄 View Original Announcement (PDF)

About Symbiotec Pharmalab Ltd (SYMBIOTEC)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹6,197.7 Cr

View full SYMBIOTEC stock details →

📡 Get AI alerts when SYMBIOTEC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SYMBIOTEC — Free

📊 More SYMBIOTEC filings

See all SYMBIOTEC filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SYMBIOTEC files new disclosures

Track SYMBIOTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SYMBIOTEC — Free

Free account · 2 AI queries/day